Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01823406 · ClinicalTrials.gov registry record · NA
Tissue-Specific Metabolic Reprogramming in Diabetic Complications
A NA study of Type 1 Diabetes Mellitus, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT01823406 is a NA study of Type 1 Diabetes Mellitus that has completed, run by University of Michigan. The registered enrollment target is 35 participants, below the 140-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01823406, a NA study of Type 1 Diabetes Mellitus, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
We will perform blood sugar studies to assess changes in metabolic (biochemical processes that occur within us) profiles associated with high blood sugar and diabetes.
Conditions Studied
Interventions
- PROCEDURE Euglycemic clamp (normal blood sugar clamp) for 4 hours
- PROCEDURE hyperglycemic clamp (elevated blood sugar to 300) for 4 hours
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-05 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01823406
The ClinicalTrials.gov registry entry for NCT01823406 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 140-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (75% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Euglycemic clamp (normal blood sugar clamp) for 4 hours is the first listed.
NCT01823406 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01823406 about?
NCT01823406 is a clinical study titled "Tissue-Specific Metabolic Reprogramming in Diabetic Complications". We will perform blood sugar studies to assess changes in metabolic (biochemical processes that occur within us) profiles associated with high blood sugar and diabetes.
What is the current status of trial NCT01823406?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2012-05. Estimated completion is 2017-08.
What conditions does trial NCT01823406 study?
This clinical trial studies the following conditions: Type 1 Diabetes Mellitus.
What interventions are being tested in trial NCT01823406?
The interventions under investigation include: Euglycemic clamp (normal blood sugar clamp) for 4 hours (PROCEDURE), hyperglycemic clamp (elevated blood sugar to 300) for 4 hours (PROCEDURE).
Who is sponsoring clinical trial NCT01823406?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01823406 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
RECRUITING · NA
-
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
RECRUITING · NA
-
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
RECRUITING · NA
-
PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.